Skip Navigation LinksHome > August 2014 - Volume 64 - Issue 2 > Identifying and Overcoming Obstacles in Angiogenic Gene Ther...
Text sizing:
A
A
A
Journal of Cardiovascular Pharmacology:
doi: 10.1097/FJC.0000000000000107
Drugs in the Pipeline

Identifying and Overcoming Obstacles in Angiogenic Gene Therapy for Myocardial Ischemia

Rubanyi, Gabor M. MD, PhD

Collapse Box

Abstract

Well-developed coronary collateral vessels in patients with symptomatic coronary artery disease were shown to be associated with reduced future cardiovascular morbidity and mortality. However, the majority of patients with coronary artery disease lack adequate functional coronary collateral circulation. Stimulation of collateral vessel development by angiogenic growth factor therapy (therapeutic angiogenesis) has been tested in many clinical trials in the past, but the potential of this new treatment paradigm has not been realized yet in late stage clinical trials. Mechanistic insights into collateral vessel development and the collective clinical experience in the past decade identified specific obstacles that might have impeded the progress in the field. This review identifies some of the key conceptual, technical, and clinical hurdles and recommends strategies to overcome them in future clinical trials.

Copyright © 2014 by Lippincott Williams & Wilkins

Follow Us!

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.